The combination of chemerin and CCLR2 induces leukocyte chemotaxis and the expression of CCRL2 in tumor cells can increase the local activity of chemotherapy drugs, inhibit neovascularization, and subsequently inhibit tumor growth 9. Here, RARRES2 is linked to neoplasm.